Longevity Biomedical (Longevity Biomedical) Dividend Payout Ratio : 0.00 (As of . 20)

View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Dividend Payout Ratio?

Longevity Biomedical's dividend payout ratio for the months ended in . 20 was 0.00.

The historical rank and industry rank for Longevity Biomedical's Dividend Payout Ratio or its related term are showing as below:

LBIO's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-20), the Dividend Yield % of Longevity Biomedical is 0.00%.

Longevity Biomedical's Dividends per Share for the months ended in . 20 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Longevity Biomedical Dividend Payout Ratio Historical Data

The historical data trend for Longevity Biomedical's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Dividend Payout Ratio Chart

Longevity Biomedical Annual Data

Trend

Dividend Payout Ratio

Longevity Biomedical Semi-Annual Data

Dividend Payout Ratio

Competitive Comparison of Longevity Biomedical's Dividend Payout Ratio

For the Biotechnology subindustry, Longevity Biomedical's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Dividend Payout Ratio falls into.

Longevity Biomedical Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Longevity Biomedical's Dividend Payout Ratio for the fiscal year that ended in . 20 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: . 20 )	/	EPS without NRI (A: . 20 )
	=		/
	=	N/A

Longevity Biomedical's Dividend Payout Ratio for the quarter that ended in . 20 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: . 20 )	/	EPS without NRI (Q: . 20 )
	=		/
	=	N/A

Longevity Biomedical (NAS:LBIO) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Longevity Biomedical Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011

Website

https://www.longevitybiomedical.com

Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines